Archive for the ‘life extension’ category: Page 435
Feb 5, 2019
Longevity Vision Fund: Fueling The Longevity Biotechnology Boom We’ve Been Waiting For
Posted by Paul Battista in categories: biotech/medical, life extension, robotics/AI
The longevity industry gets a boost with the launch of a $100 million venture fund, Longevity Vision Fund, focused on longevity biotechnology and artificial intelligence. The fund will invest in infrastructure projects enabling the longevity biotechnology industry.
Feb 5, 2019
What Happened to the 100,000-Hour LED Bulbs?
Posted by Caycee Dee Neely in categories: life extension, space
An excellent article on Hackaday addresses the lifetime of LED bulbs. To a certain degree, it also addresses the lifetime of LED’s themselves. However, the majority of the article investigates the various parts of the LED bulb, such as electronics and housings, and how they last. The article also addresses the issues of lumen depreciation and color change.
These issues are all important when thinking about long-term use in space applications.
Early adopters of LED lighting will remember 50,000 hour or even 100,000 hour lifetime ratings printed on the box. But during a recent trip to the hardware store the longest advertised lifetime I found was 25,000 hours. Others claimed only 7,500 or 15,000 hours. And yes, these are brand-name bulbs from Cree and GE.
Continue reading “What Happened to the 100,000-Hour LED Bulbs?” »
Feb 4, 2019
Peter Diamandis’ right hand man Sergey Young wants to reverse aging via his $100M Longevity Vision Fund
Posted by Edward Futurem in categories: biotech/medical, finance, life extension, Peter Diamandis
Great news!
Inspired by British billionaire Jim Mellon, chairman of anti-aging upstart biotech venture Juvenescence, Sergey Young unveiled a $100 million fund on Monday to catalyze the development of a comprehensive solution to counteract the damaging consequences of aging.
“I’ve never looked like my age…and with my name, I think it was predetermined that I was going to work in the space (of aging),” Young told Endpoints News. The 47-year-old considers himself a product of Peter Diamandis — the man behind the non-profit XPRIZE and venture capital fund BOLD Capital Partners — and is in charge of all things longevity at both organizations.
Feb 4, 2019
Longevity Investor Network Member Spotlight – Sebastian Aguiar
Posted by Nicola Bagalà in categories: biotech/medical, finance, life extension
Longevity Investor Network member Sebastian Aguiar discusses the rejuvenation biotechnology industry and bridging the gap between research and development.
Sebastian Aguiar is a Venture Fellow at Apollo Ventures, an aging-focused venture capital fund and company builder that invests across Europe and the United States. He can be found at https://www.linkedin.com/in/sebastianaguiar/ and https://twitter.com/sebastian_gero.
What initially attracted you to aging as a general discipline?
Continue reading “Longevity Investor Network Member Spotlight – Sebastian Aguiar” »
Feb 2, 2019
AHS18 Michael Rose — Evolutionary Biology of Diet, Aging, and Mismatch
Posted by Paul Battista in categories: biological, evolution, life extension, mathematics
Human health depends on age and evolutionary history. Firstly, adaptation is age-specific, with Hamilton’s forces of natural selection leading to much greater adaptation at earlier ages than later ages. This of course is how evolutionary biologists explain the existence of aging in the first place. Secondly, when environmental conditions change, it takes surprisingly few generations for populations to adapt to such new conditions, at least at early ages when natural selection is intense. Thirdly, at later ages, when the forces of natural selection are weak, natural selection will often fail to produce adaptation to a selective environment that is not evolutionarily ancient. All three of these themes will be illustrated using both explicit mathematical theory and findings from experimental evolution. At the end of the presentation, we will apply these general scientific insights to the case of human evolutionary history, human aging, and optimal human diets.
Brought to you by Nicola Bagalà, the Rejuvenation Roundup is our monthly digest, which takes a look at the big news stories involving the industry and helps keep you informed of current developments in the aging research field.
Welcome to the first Rejuvenation Roundup of the new year! There is quite a bit of news to go through and upcoming events to look forward to, so get comfortable and let’s get started.
LEAF News
Jan 31, 2019
Could targeting this enzyme slow aging and related diseases?
Posted by Paul Battista in categories: biotech/medical, life extension
In showing how an enzyme halts cell division by producing reactive oxygen species, scientists shed new light on the biology of aging and related diseases.
Jan 31, 2019
An amazing panel with Aubrey de Grey, Judy Campisi, and Nir Barzilai
Posted by Paul Battista in categories: genetics, life extension
Click on photo to start video.
Hosted by John Lewis of Oisin. Panel title: “A Therapeutic Revolution Against Aging”.
Aubrey de Grey, Judy Campisi, Nir Barzilai in a panel titled “A Therapeutic Revolution Against Aging”. Hosted by John Lewis of Oisin.
Continue reading “An amazing panel with Aubrey de Grey, Judy Campisi, and Nir Barzilai” »
Jan 31, 2019
Senescent Cells and Senolytics
Posted by Paul Battista in categories: biotech/medical, life extension
As your body ages, increasing amounts of your cells enter into a state of senescence. Senescent cells do not divide or support the tissues of which they are part; instead, they emit a range of potentially harmful chemical signals that encourage nearby cells to enter the same senescent state.
Their presence causes many problems: they degrade tissue function, increase levels of chronic inflammation, and can even eventually raise the risk of cancer. Today, we will talk about what senescent cells are, how they contribute to age-related diseases, and, perhaps most importantly, what science is hoping to do about the problem.